| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
EVE Stock Overview
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally.
Evolva Holding SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF0.095 |
| 52 Week High | CHF0.18 |
| 52 Week Low | CHF0.08 |
| Beta | 0.71 |
| 1 Month Change | 6.26% |
| 3 Month Change | 4.51% |
| 1 Year Change | -44.19% |
| 3 Year Change | -44.90% |
| 5 Year Change | -77.36% |
| Change since IPO | -92.39% |
Recent News & Updates
Shareholder Returns
| EVE | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | -0.9% | -1.6% | -0.1% |
| 1Y | -44.2% | -27.9% | -12.2% |
Return vs Industry: EVE underperformed the Swiss Chemicals industry which returned -25.3% over the past year.
Return vs Market: EVE underperformed the Swiss Market which returned -11.5% over the past year.
Price Volatility
| EVE volatility | |
|---|---|
| EVE Average Weekly Movement | 7.4% |
| Chemicals Industry Average Movement | 5.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in CH Market | 7.5% |
| 10% least volatile stocks in CH Market | 2.4% |
Stable Share Price: EVE is more volatile than 75% of Swiss stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: EVE's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 68 | Christian Wichert | https://www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA Fundamentals Summary
| EVE fundamental statistics | |
|---|---|
| Market Cap | CHF102.88m |
| Earnings (TTM) | -CHF41.27m |
| Revenue (TTM) | CHF9.88m |
10.4x
P/S Ratio-2.5x
P/E RatioIs EVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EVE income statement (TTM) | |
|---|---|
| Revenue | CHF9.88m |
| Cost of Revenue | CHF18.68m |
| Gross Profit | -CHF8.81m |
| Other Expenses | CHF32.46m |
| Earnings | -CHF41.27m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 25, 2022
| Earnings per share (EPS) | -0.038 |
| Gross Margin | -89.15% |
| Net Profit Margin | -417.78% |
| Debt/Equity Ratio | 4.9% |
How did EVE perform over the long term?
See historical performance and comparison